New cancer clinical trial: Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.

Published on: October 30, 2018 at 12:00PM
Conditions:   Colon Cancer;   Digestive System Neoplasm
Interventions:   Biological: TG6002;   Drug: Flucytosine (5-FC, Ancotil)
Sponsor:   Transgene
Recruiting
https://ift.tt/2qihtXU